You are seeing these quotes based on previous browsing related to sectors such as
Martello Announces Voting Results of Annual General Meeting .
Office Properties Income Trust Prices $400 Million of 3. 450% Senior Notes Due 2031 .
2021 Dow Jones & Company, Inc.
2021 Dow Jones & Company, Inc. By Brent Kendall and Alison Sider .
2021 Dow Jones & Company, Inc.
SOURCE: Form 4 ISSUER: Consumer Portfolio Services Inc SYMBOL: CPSS FILER: Creatura Mark A TITLE: Vice President DATE TRANSACTION SHARES PRICE VALUE 9/20/21 Exercise* 58,400 $1. 57 $91,939 OWNERSHIP: 344,616 (Direct) * - 30,000 shares exercised 9 years, 4 months after vesting and 64 days before expiration. 14,400 shares exercised 6 months, 14 days before expiration.
2021 Dow Jones & Company, Inc. By Micah Maidenberg .
SOURCE: Form 4 ISSUER: Consumer Portfolio Services Inc SYMBOL: CPSS FILER: Lavin Michael T TITLE: Vice President DATE TRANSACTION SHARES PRICE VALUE 9/17/21 Exercise* 30,000 $0. 95 $28,500 9/17/21 Gift -Received 30,000 $0. 00 N/A 9/17/21 Gift -Given 30,000 $0. 00 N/A OWNERSHIP: 0 (Direct) 305,000 (Indirect) * - Exercised 67 days before expiration.
SOURCE: Form 4/A (Amended Filing) ISSUER: Sun Country Airlines Holdings Inc SYMBOL: SNCY FILER: Whitney Grant TITLE: Vice President DATE TRANSACTION SHARES PRICE VALUE 9/13/21 Exercise* 4,000 $5. 30 $21,200 9/13/21 Sale 4,000 $31. 00 $124,016 (10b5-1 Plan Indicated)** OWNERSHIP: 0 (Direct) * - Exercised 7 years, 8 months before expiration.
2021 Dow Jones & Company, Inc.
Vinco Ventures and Emmersive Entertainment Launches First NFT Streaming Movie Soundtrack and Score Produced by Grammy Winners Om'Mas Keith and Adrian L. Miller .
-- IMCIVREE is indicated for treatment of obesity and control of hunger associated with genetically confirmed loss-of-function biallelic pro-opiomelanocortin (POMC), including PCSK1, deficiency or biallelic leptin receptor (LEPR) deficiency in adults and children six years of age and above -- .
See MHRA SmPC https://www. globenewswire. com/Tracker?data=gbUptY4Kk8W7Ba93-RMoGr0yMoC7P7aALWLP7ar1qz1MoExMDoe_RRDV_8ffp6MhYfIbL5e_1FVW0w02AtBlYU6rpNfGglDxGLgW2pv0JrcXMXpGNBCKQNrO2jtNX6FQjHL9BEGOBg7L2Pq7uiGjQxUgxybXUhg1DK_minSKPPzphYFh8ijxbhL11p4CimAF5umRNq04Xfs2kJPWziwNa3RF4iL41LUzNJ-KV7lbUo0x0WIoYhs246y2mK5-TxWD4qZfEy8eo2saV3VgDlcn8-9wFwS53OolhBPYlILSZloeDMcekGgSdsPhH2XY4bPDhX0qkY4i4hXjAPuO5JjTc4-VpbNpTvwrgQxwh7rgaVAzt_vmRYhIaljDTlqH6F_S0WGyTre57A46Pxn4LgTOoQe8CkRpYMrebaBPkynE5ecpSQCgBx98IWXIZ3yqDYWifPxJue7Zsj8vyqZr9GLKW4AbbVARubRELSFDBpMbtOFNLgVlDyMoabJqC3N_jpv1zzKlRvNwzKGS5TjagEkxPZ1bNusSNHT9C-xA9AwWTsV1TwddcAnMc_TSbFJe_F15ovNAjS4ehxlX4J23YdI7aTsawpNov-_F_yTF3jF3PIuwLEQb05BXBpp7fgLutz5wCQODVKwVhktsnADthzE7KxWzpRe3ky5vrfQExFK96Tc= for IMCIVREE(vi) .
Rhythm Pharmaceuticals Announces Marketing Authorisation of IMCIVREE(R) (setmelanotide) in Great Britain .
Rhythm is a commercial-stage biopharmaceutical company committed to transforming the treatment paradigm for people living with rare genetic diseases of obesity. The Company's precision medicine, IMCIVREE (setmelanotide), was approved in November 2020 by the U. S. Food and Drug Administration (FDA) for chronic weight management in adult and pediatric patients 6 years of age and older with obesity due to POMC, PCSK1 or LEPR deficiency confirmed by genetic testing and by the European Commission (EC) in July 2021 for the treatment of obesity and the control of hunger associated with genetically confirmed loss-of-function biallelic POMC, including PCSK1, deficiency or biallelic LEPR deficiency in adults and children 6 years of age and above.
The following is a press release from Moody's: Moody's Upgrades Ratings Of Kbr, Including Cfr To Ba2 From Ba3, Rating Outlook Stable http://www. moodys. com/page/viewresearchdoc. aspx?docid=PR_454820&cid= .
2021 Dow Jones & Company, Inc. By Andrew Restuccia and Ken Thomas .